Arjuna Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Sell |
3,110
-890
| -22% | -$396K | 0.37% | 65 |
|
|
2025
Q1 | $1.94M | Sell |
4,000
-1,541
| -28% | -$747K | 0.54% | 47 |
|
|
2024
Q4 | $2.23M | Buy |
5,541
+68
| +1% | +$27.4K | 0.59% | 46 |
|
|
2024
Q3 | $2.55M | Sell |
5,473
-534
| -9% | -$248K | 0.66% | 47 |
|
|
2024
Q2 | $2.82M | Buy |
6,007
+50
| +0.8% | +$23.4K | 0.76% | 40 |
|
|
2024
Q1 | $2.49M | Buy |
5,957
+1,339
| +29% | +$560K | 0.71% | 42 |
|
|
2023
Q4 | $1.88M | Buy |
4,618
+243
| +6% | +$98.9K | 0.59% | 51 |
|
|
2023
Q3 | $1.52M | Buy |
4,375
+29
| +0.7% | +$10.1K | 0.55% | 56 |
|
|
2023
Q2 | $1.53M | Sell |
4,346
-22
| -0.5% | -$7.74K | 0.54% | 54 |
|
|
2023
Q1 | $1.38M | Sell |
4,368
-3,069
| -41% | -$967K | 0.54% | 53 |
|
|
2022
Q4 | $2.15M | Buy |
7,437
+243
| +3% | +$70.2K | 0.99% | 34 |
|
|
2022
Q3 | $2.08M | Buy |
+7,194
| New | +$2.08M | 1.02% | 29 |
|
|
2020
Q4 | – | Sell |
-4,151
| Closed | -$1.13M | – | 102 |
|
|
2020
Q3 | $1.13M | Buy |
4,151
+55
| +1% | +$15K | 0.7% | 45 |
|
|
2020
Q2 | $1.19M | Buy |
+4,096
| New | +$1.19M | 0.82% | 43 |
|
|
2019
Q3 | – | Sell |
-2,218
| Closed | -$406K | – | 95 |
|
|
2019
Q2 | $406K | Buy |
2,218
+258
| +13% | +$47.2K | 0.29% | 76 |
|
|
2019
Q1 | $361K | Buy |
1,960
+141
| +8% | +$26K | 0.28% | 79 |
|
|
2018
Q4 | $302K | Buy |
1,819
+12
| +0.7% | +$1.99K | 0.28% | 80 |
|
|
2018
Q3 | $349K | Sell |
1,807
-4
| -0.2% | -$773 | 0.26% | 82 |
|
|
2018
Q2 | $308K | Buy |
+1,811
| New | +$308K | 0.25% | 81 |
|